There are currently only two FDA-approved medications for the treatment of posttraumatic stress disorder (PTSD) in the United States. Both of these medications are serotonin uptake inhibitors. Despite the availability of these medications, many people diagnosed with PTSD remain symptomatic, highlighting the need for new medications for PTSD treatment. However, investigators have observed that individuals diagnosed with PTSD, and who happened to also be treated with ARBs or ACE inhibitors, exhibited fewer PTSD-like symptoms.
[DLMURL="http://feeds.sciencedaily.com/~r/sciencedaily/mind_brain/ptsd/~3/kYTd9YnXNSM/140611093354.htm"]Continue reading...[/DLMURL]
[DLMURL="http://feeds.sciencedaily.com/~r/sciencedaily/mind_brain/ptsd/~3/kYTd9YnXNSM/140611093354.htm"]Continue reading...[/DLMURL]
Last edited by a moderator:
